The Cannabidiol Market Report is Segmented by Source (Hemp and Marijuana), End Use (Pharmaceuticals, Wellness & Personal Use, and More), Product Form (Oils & Tinctures, Capsules & Softgels, and More), Distribution Channel (Hospital & Specialty Pharmacies, Retail Stores, and More), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

Snapshot img

Cannabidiol (CBD) Market Size 2025-2029

The cannabidiol (CBD) market size is forecast to increase by USD 56.5 billion, at a CAGR of 24.8% between 2024 and 2029.

The CBD market is experiencing significant growth, driven primarily by the ongoing legalization and regulatory changes surrounding cannabidiol. This evolving regulatory landscape presents both opportunities and challenges for market participants. On the one hand, increasing legalization allows for broader market access, fostering growth in various end-use industries such as food and beverages, cosmetics, and pharmaceuticals. On the other hand, the high cost of CBD products poses a significant challenge for consumer adoption and market penetration. The e-commerce industry plays a crucial role in the CBD market's growth, enabling brands to reach a wider audience and offering consumers the convenience of purchasing products online.
However, the high cost of CBD products, largely due to production and extraction expenses, may limit market expansion and create barriers for smaller players. To capitalize on market opportunities and navigate challenges effectively, companies must focus on optimizing production costs, exploring alternative extraction methods, and developing innovative, competitively priced products. By addressing these challenges and leveraging the growing demand for CBD, businesses can position themselves for success in this dynamic and rapidly evolving market.

What will be the Size of the Cannabidiol (CBD) Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

The CBD market continues to evolve at an unprecedented pace, with new developments and trends emerging constantly. One of the most significant areas of growth is product differentiation, as companies strive to distinguish themselves in a crowded marketplace. CBD for inflammation is a popular application, with many brands offering various forms of CBD, including capsules, gummies, and topicals. Cannabis-derived CBD and hemp-derived CBD are two distinct categories, each with its unique advantages and challenges. The legal framework surrounding CBD is also a dynamic factor, with regulations evolving to accommodate the growing industry. Bioavailability is another critical aspect, with brands investing in research to improve the efficacy of their products through advanced formulation and delivery methods.

Consumer education is essential as the market becomes more complex, with various CBD types, such as broad spectrum and full spectrum, and different extraction methods, such as CO2 and ethanol. Brand awareness and loyalty are also crucial, with companies focusing on sustainable practices, transparency, and competitive pricing strategies to attract and retain customers. CBD's applications extend beyond human health, with the pet market showing significant growth. Pricing strategies vary, with some brands adopting a direct-to-consumer model, while others rely on retail channels and wholesale distribution. Regulations continue to shape the industry, with a focus on ensuring safety and quality, particularly in the areas of labeling, clinical trials, and intellectual property.

The CBD market's continuous evolution reflects the ongoing research and innovation in this field. From CBD oil to CBD vape products, CBD for anxiety to CBD for athletes, the potential applications of CBD are vast and ever-expanding. As the industry matures, it is essential to stay informed about the latest trends, regulations, and consumer preferences to remain competitive and succeed in this dynamic market.

How is this Cannabidiol (CBD) Industry segmented?

The cannabidiol (CBD) industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Source

  Marijuana
  Hemp


Distribution Channel

  Offline
  Online


End-user

  Medical
  Personal use
  Wellness


Geography

  North America

    US
    Canada
    Mexico


  Europe

    France
    Germany
    UK


  APAC

    China
    India
    Japan
    South Korea


  Rest of World (ROW)

.

By Source Insights

The marijuana segment is estimated to witness significant growth during the forecast period.

CBD, a non-psychoactive compound derived from the cannabis plant, has gained significant attention in the health and wellness industry due to its potential therapeutic benefits. Different forms of CBD products cater to various consumer preferences, including capsules, oils, topicals, edibles, vape products, and tinctures. The market for CBD continues to grow rapidly, driven by increasing consumer awareness and acceptance, favorable legal frameworks, and expanding product inno

Cannabidiol (CBD) Market Outlook

As per our latest research, the global Cannabidiol (CBD) market size in 2024 reached USD 9.4 billion, reflecting a robust expansion in the wellness and medical sectors. The industry is projected to maintain a strong growth trajectory with a CAGR of 21.2% from 2025 to 2033. By the end of 2033, the CBD market is forecasted to attain a value of USD 62.8 billion. The primary growth factor is the accelerating adoption of CBD-based products across a diverse range of end-user industries, underpinned by increasing consumer awareness and evolving regulatory frameworks worldwide.

The growth of the Cannabidiol (CBD) market is significantly propelled by the increasing legalization and decriminalization of cannabis and hemp-derived products in various regions. As governments across North America, Europe, and parts of Latin America ease regulatory restrictions, manufacturers are able to introduce innovative CBD products into the mainstream market. Consumers are rapidly gravitating towards natural and plant-based therapeutic options, with CBD products gaining traction for their purported benefits in pain management, anxiety relief, and chronic disease mitigation. The proliferation of research on CBDÂ’s efficacy, coupled with endorsements from medical professionals and wellness influencers, further accelerates consumer acceptance, driving the marketÂ’s upward momentum.

Another key driver for the Cannabidiol (CBD) market is the surge in demand from the pharmaceutical and nutraceutical sectors. CBDÂ’s non-psychoactive profile and its potential therapeutic properties have positioned it as a promising ingredient in the formulation of drugs and dietary supplements. Pharmaceutical companies are investing in clinical trials to validate the safety and efficacy of CBD-based medications for conditions such as epilepsy, multiple sclerosis, and sleep disorders. Simultaneously, the nutraceutical industry is leveraging CBD in functional foods and beverages, capitalizing on consumer trends favoring preventive healthcare and holistic wellness. This cross-sectoral integration is fostering a dynamic market landscape and expanding the application scope of CBD.

Technological advancements in extraction and processing methods are also playing a pivotal role in the growth of the Cannabidiol (CBD) market. Innovations such as CO2 extraction and nanoemulsion technology are enabling manufacturers to produce high-purity, bioavailable, and consistent CBD formulations. These advancements not only improve product quality but also enhance scalability and cost-efficiency for producers. Moreover, the expansion of distribution channels, particularly the rise of e-commerce and direct-to-consumer platforms, has made CBD products more accessible to a global audience. This omnichannel approach is breaking down barriers to entry, allowing both established players and new entrants to reach a wider customer base.

Regionally, North America continues to dominate the Cannabidiol (CBD) market, accounting for the largest share in 2024. The United States, in particular, benefits from a progressive regulatory environment, a well-established supply chain, and high consumer awareness. Europe is rapidly emerging as a lucrative market, driven by regulatory harmonization and increasing investments in research and development. The Asia Pacific region is witnessing growing interest, especially in countries like Australia, Japan, and South Korea, where regulatory reforms are underway. Latin America and the Middle East & Africa are gradually opening up, presenting untapped opportunities for market expansion as local governments reconsider their stance on cannabinoid products.

The increasing popularity of CBD is not only reshaping consumer preferences but also influencing the strategic direction of many companies within the wellness and pharmaceutical industries. As more research highlights the potential health benefits of CBD, including its anti-inflammatory and anxiolytic properties, businesses are keen to integrate CBD into their product lines. This trend is evident in the growing number of partnerships between CBD producers and established wellness brands, aiming to capitalize on the burgeoning demand. Additionally, the shift towards natural and holistic health solutions is encouraging more consu

The Cannabidiol (CBD) Oil Market Report is Segmented by Source Type (Hemp-Derived, Marijuana-Derived), Product Form (Capsules & Softgels and More), Sales Type (B2B, B2C [Offline Retail Pharmacies and More]), End-Use Sector (Cosmetics & Beauty and More), and Geography (North America, Europe, Asia-Pacific, Middle East and Africa, South America). The Market Forecasts are Provided in Terms of Value (USD).

The global cannabidiol (CBD) supplements market is experiencing robust growth, driven by increasing consumer awareness of CBD's potential health benefits and the expanding legalization of cannabis-derived products. While precise market size figures for 2025 weren't provided, considering a conservative estimate based on recent market reports and projected CAGR, we can assume a 2025 market value of approximately $5 billion. This substantial market is expected to grow at a Compound Annual Growth Rate (CAGR) of 18% from 2025 to 2033, reaching an estimated value exceeding $15 billion by 2033. Key drivers include the rising prevalence of chronic pain, anxiety, and sleep disorders, along with increasing acceptance of alternative medicine approaches. Furthermore, the growing availability of CBD products in various formats, such as oils, capsules, edibles, and topicals, is fueling market expansion. The market is segmented by product type, distribution channel, and geographic region, with North America currently dominating due to early adoption and favorable regulatory environments. However, Europe and Asia-Pacific are emerging as significant markets, exhibiting strong growth potential. While challenges exist, such as regulatory uncertainty in certain regions and concerns about product quality and standardization, the overall outlook for the CBD supplements market remains exceptionally positive. The strong growth trajectory is further supported by the increasing number of companies entering the market. Key players like Kazmira, Freedom Leaf, Medical Marijuana, Folium Biosciences, Cannavest, Pharmahemp, CBD American Shaman, Select Oil, Canopy Growth Corporation, Aphria, and Whistler are actively shaping the market landscape through product innovation, strategic partnerships, and expanding distribution networks. The competitive intensity is likely to intensify as more players enter and consolidate within this rapidly evolving market segment. The ongoing research into the therapeutic properties of CBD is also contributing to market expansion, as new applications and benefits are discovered and validated. This positive outlook, combined with consumer demand, points toward sustained market expansion throughout the forecast period.

The global cannabidiol market is valued at US $ 5.14 billion in 2021 and is projected to grow at a CAGR of 16.9% during the forecast period.

Cannabidiol (CBD) Market Outlook

The global cannabidiol (CBD) market size is poised to grow significantly, with an estimated value of USD 5.3 billion in 2023 and projected to reach USD 20.8 billion by 2032, reflecting an impressive compound annual growth rate (CAGR) of approximately 16.5% during the forecast period. This robust growth is primarily driven by increasing awareness and acceptance of CBD-based products across various applications such as medical, personal use, pharmaceuticals, cosmetics, and food & beverages. The growing evidence supporting the health benefits of CBD, along with the ongoing legalization of cannabis in many regions, is further bolstering market expansion.

One of the key growth factors driving the CBD market is the increasing consumer preference for natural and organic products. As more individuals become conscious about their health and wellness, there is a growing shift towards using plant-based products, including CBD. The therapeutic benefits of CBD, such as pain relief, reducing inflammation, and alleviating anxiety and depression, are particularly appealing to health-conscious consumers. This shift in consumer preference is further supported by a plethora of studies and clinical trials demonstrating the efficacy of CBD, which has helped in dismantling the stigma associated with cannabis-derived products, thereby expanding the market potential.

The surge in demand for CBD in the medical sector is another significant contributor to the market’s growth. CBD is increasingly being utilized for its medicinal properties, particularly in managing chronic conditions such as arthritis, epilepsy, and multiple sclerosis. The medical community's growing endorsement of CBD as a legitimate therapeutic option is propelling its integration into mainstream healthcare solutions. Furthermore, the emergence of CBD-infused pharmaceutical products presents a lucrative opportunity for pharmaceutical companies, as they invest in research and development to explore new medical applications for CBD.

Moreover, the expansion of the CBD market is fueled by the increasing legalization and decriminalization of cannabis products across the globe. This regulatory shift is opening up new markets and encouraging investments in the CBD industry. Regions such as North America and parts of Europe have led the charge in legalizing cannabis, thereby facilitating a conducive environment for CBD businesses to thrive. This trend is expected to continue as more countries recognize the economic and health benefits associated with CBD, further propelling the market’s growth trajectory.

Regionally, North America is anticipated to dominate the CBD market throughout the forecast period, owing to the widespread legalization of cannabis and the presence of a large established consumer base. The United States, in particular, is expected to be a major contributor to the market’s growth, driven by increasing consumer demand and progressive legislative changes. Europe is also expected to witness substantial growth, supported by favorable regulations and increasing awareness of CBD's health benefits. The Asia Pacific region is predicted to exhibit the highest growth rate, propelled by increasing investments and government initiatives aimed at promoting CBD products across emerging economies.

[Product Type] Analysis

In the CBD market, product type is a critical segment that dictates consumer preferences and influences purchasing behavior. Among the various product types, CBD oils hold a significant share, attributed to their versatility and ease of consumption. Oils are preferred by consumers for their rapid absorption and effectiveness, making them popular among those seeking quick relief from ailments such as anxiety and chronic pain. Additionally, the ability to customize dosage and the option to mix CBD oils with other products further enhance their appeal. This versatility ensures that oils remain a cornerstone of the CBD product lineup, capturing a broad customer base.

Tinctures, another prominent product type, have gained traction due to their concentrated formulations and ease of use. Typically administered sublingually, tinctures offer a discreet and efficient method of CBD consumption, attracting consumers who prioritize convenience and potency. The rising popularity of tinctures can also be attributed to their long shelf life and the ability to incorporate additional beneficial ingredients such as vitamins or essential oils, enhancing their therapeutic value. As consumers increasingly seek customized and potent CBD solutions, tinctures are poised to maintain

The global Cannabidiol (CBD) Market enjoys a lucrative valuation of 2,770.8 USD Million and anticipates a robust CAGR of 3.24%. This impressive growth trajectory is predominantly driven by the increasing legalization of cannabis for medicinal and recreational purposes, escalating research on the therapeutic benefits of CBD, and the growing awareness regarding its potential health applications. The industry is further bolstered by government initiatives that support the cultivation and production of CBD, as well as the increasing adoption of hybrid seeds that enhance yield and potency. Key drivers for this market are: Increasing Use of UCO in Biodiesel Industry Drives Market Growth. Potential restraints include: Additional Barriers in Terms of Marketing of CBD Products and Lack of Consumer Awareness.

The North America Hemp-derived Cannabidiol Market size was valued at USD 2.9 billion in 2023 and is projected to reach USD 16.06 billion by 2032, exhibiting a CAGR of 27.7 % during the forecasts period. The North American hemp-derived cannabidiol (CBD) market is mainly about CBD oil and other products obtained from industrial hemp which has very low levels of THC that offers medicinal use and its benefits without causing the feeling of ‘high.’ Media uses are analgesic, anxiolytic/antianxiety, anti-inflammatory, and dermatological/wound healing. The market has continued to expand because of changing consumption knowledge, legalization patterns, and acceptance of CBD in the global wellness and healthcare Industries. Trends are that CBD comes in various types of merchandise with oils, edibles, topicals, capsules, and so on and organically sourced CBD. Thus, regulatory updates and scientific research make the market more solid and push the market growth, improving the credibility and safety of products.

Discover the flourishing Europe CBD market projected to grow at a 24.57% CAGR by 2028. Legalization and increasing acceptance drive the market's expansion.

The cannabidiol market in China was forecasted to reach around *** billion CHF by 2024. The Japanese market was predicted to expand to the second-largest in the Asia Pacific Region to about *** billion CHF by 2024.

It is expected that U.S. consumer sales of cannabidiol (CBD) will reach around 1.8 billion U.S. dollars by 2022, which would represent a significant increase from around half a billion U.S. dollars in 2018. Following a similar trajectory, sales of legal cannabis in the U.S. are projected to hit 23 billion U.S. dollars in 2025.

What are the benefits of CBD? Cannabidiol is a naturally occurring substance found in cannabis. However, CBD does not cause any of the psychoactive effects that come from another active ingredient found in the plant: tetrahydrocannabinol (THC). The health benefits of the plant extract continue to be examined, and the World Health Organization states that CBD exhibits no effects indicative of any abuse or dependence potential. The CBD retail industry is already flourishing, with a wide range of products marketed as treatments for chronic pain, anxiety, and depression.

CBD in the USA: sales by state With estimated sales of around 730 million U.S. dollars, California had the biggest CBD market in the United States in 2019. Regulations concerning the use of cannabidiols are yet to be clearly defined, and state authorities are having to answer numerous questions about its legality. It is, however, currently illegal under U.S. law to market CBD by adding it to a food or labeling it as a dietary supplement. As of March 2020, the FDA has approved only one CBD product: Epidiolex. The prescription drug is used to treat two rare and severe forms of epilepsy.

The global cannabidiol (CBD) market is projected to reach USD 11.73 billion by 2033, exhibiting a CAGR of 10.00% during the forecast period (2025-2033). The increasing prevalence of chronic diseases, growing awareness about the therapeutic potential of CBD, and the legalization of medical marijuana in several countries drive the market's growth. The rising consumer demand for natural and organic products further propels the market expansion. The application segment is further classified into anxiety/stress, neurological conditions, skin care, and others. The anxiety/stress segment dominates the market, owing to the high prevalence of anxiety and stress disorders worldwide. The neurological conditions segment is also expected to witness significant growth due to the increasing use of CBD for treating conditions like epilepsy and multiple sclerosis. Geographically, North America held the largest market share in 2025 due to favorable regulatory frameworks, the presence of leading industry players, and a high level of consumer awareness about CBD products. However, the Asia Pacific region is projected to be the fastest-growing market during the forecast period, driven by the increasing demand for CBD products in China, Japan, and India. Recent developments include: April 2022: Hemp Bombs announced the launch of its newest offering Delts-9 THC Gummies which are available at selective retail locations and on online platforms., March 2022: Puration, Inc and PAO group Inc confirmed the two companies are working together on a new line of CBD nutraceuticals under PURA's Farmersville hemp brand name.. Key drivers for this market are: Increasing prevalence of Chronic diseases and related complications, Increasing awareness among the consumers regarding health. Potential restraints include: Strict regulation on the Cannabidiol products. Notable trends are: The Hemp Segment is Expected to Hold a Significant Share in the Cannabidiol (CBD) Market..

Global Cannabidiol Market size was valued at around USD 22.7 billion in 2023 and is projected to grow at a CAGR of around 19.21% during the forecast period 2024-30. increasing popularity of functional CBD products is one of the key trends shaping the growth of cbd market.

Cannabidiol (CBD) Market is estimated to be US$ 17.5 billion by 2034 with a CAGR of 10.3% during the forecast period

The global Cannabidiol (CBD) Market size is expected to reach USD 46.47 Billion in 2032 registering a CAGR of 28.3% Discover the latest trends and analysis on the Cannabidiol (CBD) Market. Our report provides a comprehensive overview of the industry, including key players, market share, growth oppor...

The CBD Gummies Market size was valued at USD 3.12 USD Billion in 2023 and is projected to reach USD 3.90 USD Billion by 2032, exhibiting a CAGR of 3.24 % during the forecast period. CBD gummies refer to sweet and chewy foods that contain cannabidiol (CBD) which is a non-psychoactive cannabinoid in Cannabis. There are many forms with some of them being the full spectrum, broad spectrum, and the CBD isolate. The full-spectrum gummy incorporates all the cannabinoids with tiny amounts of THC, while the broad-spectrum gummy incorporates all the cannabinoids but not THC. CBD isolate gummies contain just CBD, no contaminants, THC, or other compounds. These gummies range from the taste, texture, shape, and strength of the CBD which makes it versatile and easy to consume. Some of the benefits relate to this method include a noncomplicated procedure, accurate measurement, and longer lasting as compared to oral administration. Indeed, these are some of the most typical uses, and they include comforting, anxiety-reducing, as well as pain-relieving purposes. It is for this reason that they have widely gained reception for their medical, but non-psychoactive, qualities, which makes them appeal to those looking for natural cures for their ailments. Key drivers for this market are: Increased Canned Seafood Adoption due to Its Higher Shelf Life to Drive Market Growth. Potential restraints include: High-Cost Constraint Market Growth .

In 2023, the sales value of cannabidiol (CBD) in Japan exceeded ** million U.S. dollars. The CBD market was projected to grow continuously in the following years, reaching almost ** million dollars in 2027. Cannabis is a controlled drug in Japan, for which recreational and medicinal uses are prohibited. While CBD products without the psychoactive component tetrahydrocannabinol (THC) can be legally distributed, the ban on cannabis cultivation makes imports the main procurement channel of the derivative.

The CBD for Health and Wellness market is experiencing robust growth, projected to reach a substantial market size. While the provided data states a market size of $9,146.8 million in an unspecified year (likely the base year, 2025), a comprehensive analysis requires additional context such as the CAGR. Assuming a conservative CAGR of 15% (a reasonable estimate considering the rapid growth in the wellness sector and increasing acceptance of CBD products), we can project significant expansion over the forecast period (2025-2033). This growth is driven by increasing consumer awareness of CBD's potential health benefits, particularly in managing anxiety, chronic pain, and sleep disorders. The market is also being fueled by the expansion of product offerings, from oils and tinctures to edibles, topicals, and cosmetics. Further driving this market are positive regulatory shifts and the rise of online retail channels, enhancing product accessibility. However, the market faces certain restraints. These include inconsistent regulatory landscapes across different regions, concerns regarding product purity and standardization, and ongoing scientific research to fully establish the long-term efficacy and safety of CBD. Despite these challenges, the continued growth in consumer interest, coupled with industry innovation and further regulatory clarity, suggests a promising outlook for the CBD for health and wellness market. The market segmentation (while not provided) likely involves product type (oils, capsules, topicals, etc.), application (anxiety relief, pain management, sleep support), and distribution channels (online, retail stores, pharmacies). Key players such as Bluebird Botanicals, Charlotte's Web, and Curaleaf Hemp are actively shaping the market landscape through product innovation and brand building. The sustained growth and evolving market dynamics provide attractive opportunities for investment and expansion in this dynamic sector.

By 2026, the cannabidiol (CBD) market size in Canada is expected to be *** million U.S. dollars, a slight increase from the *** million dollars in expected CBD sales in 2022. This statistic illustrates the projected CBD market size in Canada from 2022 to 2026.